Efficacy of olaparib combined with dabrafenib and trametinib for a patient with BRAF mutated and ATM deleted metastatic melanoma - Vigipallia

0 avis

Efficacy of olaparib combined with dabrafenib and trametinib for a patient with BRAF mutated and ATM deleted metastatic melanoma

Archive ouverte

Marguet, Theo | Mouret, Stéphane | Belbézier, Aude | Castillo-Ferrer, Camila | Sancey, Lucie | Porret, Pauline | Templier, Isabelle | Hurbin, Amandine | Frachet, Véronique | Amini-Adle, Mona | Malissen, Nausicaa | Charles, Julie

Edité par CCSD ; Wiley -

International audience

Langue: en

Consulter en ligne

Consulter le document

Suggestions

Du même auteur

Efficacy of olaparib combined with dabrafenib and trametinib for a patient with BRAF mutated and ATM deleted metastatic melanoma

Archive ouverte | Marguet, Theo | CCSD

International audience

Efficacy of olaparib combined with dabrafenib and trametinib for a patient with BRAF mutated and ATM deleted metastatic melanoma

Archive ouverte | Marguet, Theo | CCSD

International audience. No abstract available

Serum IGF1 Is a Prognostic Marker for Resistance to Targeted Therapies and a Predictive Marker for Anti-IGF1 Receptor Therapy in Melanoma

Archive ouverte | Castillo-Ferrer, Camila | CCSD

International audience

Chargement des enrichissements...